Skip to content

Clinical trials

Completed Atherosclerosis trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Status: Completed Country / region: Hong Kong Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20062
20083
20121
20182
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Tuen Mun Hospital2
Abbott Medical Devices1
Amgen1
Asan Medical Center1
AstraZeneca1
CSL Behring1
Chinese University of Hong Kong1
Sanofi1
The University of Hong Kong1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis12
Cardiovascular Diseases3
Coronary Artery Disease2
Heart Diseases2
Ischemic Stroke2
Stroke2
Acute Coronary Syndrome1
Atrial Fibrillation1
Cerebral Infarction1
Constriction, Pathologic1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.